Search Results
Lilly antibody drug fails in COVID-19 study; others go on
Eli Lilly antibody drug fails in COVID-19 study
Lilly antibody drug study halted
Coronavirus: Eli Lilly launches first human trial of a new type of treatment
Eli Lilly CEO discusses its coronavirus antibody drug and the latest on its breast cancer treatment
Bamlanivimab - Eli Lilly new monoclonal antibody LY-555 for treatment of COVID-19
Experimental Antibody Drug Protected Patients from COVID-19, Eli Lilly Claims
Eli Lilly CEO David Ricks explains how the company’s new covid-19 therapies help patients
Eli Lilly halts treatment trial
Working Towards an Effective Treatment for COVID-19: The ACTIV-2 Trial by Kara Chew, MD, MS
Eli Lilly CEO talks partnering with AbCellera Biologics to co-develop a coronavirus cure
A Case of Reinfection. Johnson and Johnson and Eli Lilly Pause Their Trials